Publications Digest

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Pimenta et al. systematically reviewed approaches for selecting and prioritizing medical devices for health technology assessment (HTA).

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Sustainability Publications Digest. In a recent publication, Eussen et al. conducted a global survey on surgeons’ perspectives regarding disposable and reusable surgical materials in laparoscopic cholecystectomy.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Health Economic Publications Digest. In a recent publication, Henderson et al. analyzed the landscape of open-source health economic models through a systematic review of 11 databases and repositories.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Basile et al. reviewed the role of meta-analyses in evidence-based medicine.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Sustainability Publications Digest. In a recent publication, Cunha et al. systematically reviewed the environmental impact of open, laparoscopic, and robotic surgeries.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Health Economic Publications Digest. In a recent publication, Maervoet et al. compared the newly recommended NICE Decision Support Unit (DSU) mapping function for EQ-5D-5L to EQ-5D-3L with the previously endorsed van Hout Crosswalk.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Barrette et al. examined how existing real-world evidence (RWE) guidance for hypothesis-evaluating treatment effectiveness (HETE) studies applies to non-HETE analyses.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its EU HTA Publications Digest. In a recent publication, Boers et al. introduced the Common European Classification Grid (CEUGrid-DMD) and an Evidence Matrix to harmonize the evaluation of digital medical devices (DMDs) across the EU.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Sustainability Publications Digest. In a recent publication, van-Hove et al. analysed the carbon footprint of cataract surgery in England and the potential impact of adopting the NHS “Getting It Right First Time” (GIRFT) High Volume Low Complexity (HVLC) pathway.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Health Economic Publications Digest. In a recent publication, van Lieshout et al. examined how different stakeholders view the role of early health economic analyses (EHEA) in developing health innovations in the Netherlands.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Blanchard et al. explored the role of health technology assessment (HTA) in France beyond reimbursement and access to innovation.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its EU HTA Publications Digest. In a recent publication, Eberle et al. explored whether the PICO elements (Population, Intervention, Comparator, Outcome) applied in EU Joint Clinical Assessments (JCAs) can be predicted across member states using publicly available data from national HTA bodies.